Trial Profile
The effect of Xenical [orlistat] on weight, risk factors and burden of medication.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 24 Sep 2008 Planned end date changed from 1 May 2006 to 1 Dec 2010 as reported by ClinicalTrials.gov.